Screenpoint Medical

Screenpoint Medical is a medical technology company specializing in the development of artificial intelligence-powered solutions for breast cancer screening. The company's primary product is Transpara, a software suite designed to assist radiologists in the detection and analysis of breast cancer from mammograms, including both 2D and 3D digital breast tomosynthesis images. Transpara is FDA-cleared and CE-marked, and is intended to improve the efficiency and accuracy of the reading workflow. The system provides a risk score and can be used to identify studies that require more attention, potentially allowing for earlier cancer detection and a reduction in radiologist workload. The technology is supported by extensive clinical evidence and is designed to integrate into existing breast imaging workflows to enhance confidence, particularly in cases involving dense breast tissue. Screenpoint Medical focuses on continuous updates to its deep learning algorithm to maintain high performance in a clinical setting.